Challenges in Patenting Bioartificial Organs – Presented by Nicole Anna Michels, University of Zurich / Braunpat Braun Eder AG at the 3D Bioprinting Conference which takes place on Jan 31, 2017 at MECC Maastricht in The Netherlands.
Concerns and controversies about patenting are playing a crucial role in the development and application of IP law – especially in the field of emerging biosciences. The question whether biotechnological inventions (especially methods or even products in the field of 3D-bioprinting) are per se patentable is probably going to become one of the most disputed controversies in the field of intellectual property. My research considers the boundaries of bioethics and intellectual property law in view of the ongoing research involving the use of 3D-bioprinted tissues and organs, breaks down this complex issue and analyses the patentability of 3D bioprinting in view of the current intellectual property (IP) landscape.
About Nicole Anna Michels
Nicole Anna Michels has graduated in 2011 in Biochemistry at the University of Fribourg, Switzerland, where she obtained her M.Sc. with specialization in neurobiochemistry of circadian rhythms.
About University of Zurich / Braunpat Braun Eder AG
The University of Zurich is one of the leading research universities in Europe and offers the widest range of study courses in Switzerland.The Institute of Biomedical Ethics and History of Medicine’s research includes biomedical ethics and the interface between ethics, health law and human rights. BRAUNPAT is a firm specialized in the field of intellectual and industrial property. BRAUNPAT’s workforce includes patent and trade mark specialists and lawyers as well as the appropriate infrastructure for obtaining and defending patent rights, trade mark rights, design rights and copyrights.